MilliporeSigma
Search Within
Document Type
Applied Filters:
Keyword:'parkinsons disease'
Showing 1-30 of 84 results for "

parkinsons disease

" within Technical Documents
Sort by Relevance
Product Information Sheet - M1021
mechanism. Restor. Neurol. Neurosci., 16(2), 135-142 (2000). 3. Adams, J. D., Jr., et al., Parkinson's disease - redox mechanisms. Curr. Med. Chem., 8(7), 809-814 (2001). 4. Ziering, A., et al.
Product Information Sheet - M0896
mechanism. Restor. Neurol. Neurosci., 16(2), 135-142 (2000). 3. Adams, J. D., Jr., et al., Parkinson's disease - redox mechanisms. Curr. Med. Chem., 8(7), 809-814 (2001). 4. Ziering, A., et al.
Data Sheet - S1071
gene identified in families with Parkinson's disease. Science, 276, 2045-2047 (1997). 6. Lee, M.K., et al., Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53- Thr mutation causes
Data Sheet - P5748
molecular characters in Parkinson's disease: felons, conspirators, and suspects, Ann. N.Y. Acad. Sci., 991, 80-92 (2003). 5. Chung, K.K., et al, New insights into Parkinson's disease, J Neurol., 250, Suppl
Data Sheet - P6248
al., Familial juvenile parkinsonism: clinical and pathologic study in a family, Neurology, 44, 437-441(1994). 5. Mizuno, Y., et al., Parkin and Parkinson's disease, Curr. Opin. Neurol., 14
Data Sheet - P2615
H. et al. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44, 437-441(1994). 4. Mizuno, Y., et al., Parkin and Parkinson’s disease. Curr. Opin. Neurol., 14, 477
Data Sheet - S1196
role in the pathogenesis of Parkinson's disease. FEBS Lett., 565, 1-5 (2004). 4. Iwai, A., et al., The precursor protein of non-A β component of Alzheimer's disease amyloid is a presynaptic protein
Product Information Sheet - A1260
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur. J. Neurosci., 15(1), 120-132 (2002). 9. Suckow, R. F., Separation methods for tricyclic
Data Sheet - H4038
protein aggregates produced in neuro- degenerative diseases, such a Huntington’s and Parkinson diseases.7, 8 In brain tissues from Parkinson disease patients, it has been shown that Lewy bodies (LBs
Data Sheet - P9373
gene in PARK7-linked families. Mutations in the PARK7/DJ-1 gene cause autosomal-recessive Parkinsons disease. Reagent The antibody is supplied as a solution of ~1 mg/mL in phosphate buffered saline
Data Sheet - SRP5102
expression was decreased in the mitochondrial fraction of neurons from the substantia nigra of Parkinson disease patients.2 Recombinant human Mortalin (47-end) protein was expressed in Sf9 insect cells
L-BMAA HYDROCHLORIDE
lateral sclerosis -parkinsonism- dementia linked to a plant excitant neurotoxin." Science 237, 517-522 (1987). 4. Kurland, L.T. "Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam
Data Sheet - S7820
possible role in the pathogenesis of Parkinson's disease. FEBS Lett., 565, 1-5 (2004). 4. Iwai, A., et al., The precursor protein of non-A β component of Alzheimer's disease amyloid is a presynaptic protein
Data Sheet - S4447
include Parkinson’s disease (PD), dementia with Lewy bodies (filamentous inclusions), Lewy body variant of Alzheimer’s disease, and multiple system atrophy.2 Familial parkinsonism and dementia with
Data Sheet - SAB4200531
the ZNF746 immunizing peptide. Parkinson's disease (PD) is a neurodegenerative disorder of the central nervous system (CNS). The motor symptoms of Parkinson's disease result from the death of dopaminergic
Data Sheet - SAB4200530
the ZNF746 immunizing peptide. Parkinson's disease (PD) is a neurodegenerative disorder of the central nervous system (CNS). The motor symptoms of Parkinson's disease result from the death of dopaminergic
Data Sheet - N4663
Hering, R., et al., Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology 62: 1231-1232 (2004). 3. Law, S. W., et al., Identification of a new brain-
Data Sheet - S6949
regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease. J. Biol. Chem., 279, 23622-23629 (2004). 4. Hashimoto, M., et al., β-Synuclein inhibits
Data Sheet - S6699
regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease. J. Biol. Chem., 279, 23622-23629 (2004). 4. Hashimoto, M., et al., β-Synuclein inhibits
Data Sheet - GW22371F
SNCA anti-apoptotic function abolished by 6OHDA. Not found in the Lewy bodies associated with Parkinson disease. NCBI Accession number: NP_003076.1 Swiss Prot Accession number: Q16143 Gene Information
Data Sheet - S5571
regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease. J. Biol. Chem., 279, 23622-23629 (2004). 4. Hashimoto, M., et.al., ß-Synuclein Inhibits
Data Sheet - M3571
dementia and Parkinson's. The presence of Msi-1 in a significant percentage of neurons containing cytoplasmic inclusions in two other neurodegenerative diseases, Alzheimer's disease and Pick disease, suggests
RABBIT ANTI- CYP450 2E1 POLYCLONAL ANTIBODY
from date of receipt. REFERENCES: Viaggi, C, et al (2006). Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity. J Neural Transm Suppl : 173-6.
Data Sheet - SRP5149
encodes two opposing enzymatic activities that affect alpha- synuclein degradation and Parkinson's disease susceptibility. Cell, 111, 209-218 (2002). 2. Gong, B. et al., Ubiquitin hydrolase Uch-
Data Sheet - G4046
Several studies indicate that mutations in the human GBA gene are associated with early-onset Parkinson disease. 4-5 Reagent Supplied as a solution in 0.01 M phosphate buffered saline, pH 7.4, containing
Data Sheet - G4171
Several studies indicate that mutations in the human GBA gene are associated with early-onset Parkinson disease.4-5 Reagent Supplied as a solution in 0.01 M phosphate buffered saline, pH 7.4, containing
Data Sheet - S3071
pathology in Parkinson's disease and dementia with Lewy bodies. A change in the expression of γ-synuclein has also been specifically observed in the retina of patients with Alzheimer's disease. 2 γ-
Anti-ATP13A2 (A9607)
in brains of sporadic PD patients, suggesting a potential role in the more common forms of Parkinson's disease. Reagent Supplied as a solution in 0.01 M phosphate buffered saline, pH 7.4, containing
Data Sheet - A3361
brains of sporadic PD patients, suggesting a potential role in the more common forms of Parkinson's disease. Reagent Supplied as a solution in 0.01 M phosphate buffered saline, pH 7.4, containing
"Anti-ATP13A2 (C-terminal) produced in rabbit, affinity isolated antibody"
brains of sporadic PD patients, suggesting a potential role in the more common forms of Parkinson's disease. Reagent Supplied as a solution in 0.01 M phosphate buffered saline, pH 7.4, containing
Page 1 of 3
Page 1 of 3